中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US10653652B2 Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction 有权

  • Patent Title: Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
  • Application No.: US16270856
    Application Date: 2019-02-08
  • Publication No.: US10653652B2
    Publication Date: 2020-05-19
  • Inventor: Matthew During
  • Applicant: Ovid Therapeutics Inc.
  • Applicant Address: US NY New York
  • Assignee: Ovid Therapeutics Inc.
  • Current Assignee: Ovid Therapeutics Inc.
  • Current Assignee Address: US NY New York
  • Agency: Carter, DeLuca & Farrell LLP
  • Main IPC: A61K31/196
  • IPC: A61K31/196 ;  A61P27/16
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
Abstract:
Methods of treating tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction with (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid or a pharmaceutically acceptable salt thereof are provided. Methods of treating tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction with (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction.
Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0